Franz Konrad

The independent corporation Greiner Bio-One International AG sprang from the laboratory technology division of Greiner Holding AG in 2001. It is also owned by the Greiner family and specializes in the promising Preanalytics and Bioscience sectors. With a production and distribution network in more than 100 countries worldwide and approximately 1200 employees, the company has been extremely successful in both product divisions. Greiner Bio-One is a global leader in the HTS product sector for the pharmaceutical screening of active agents. In the area of specimen sampling devices, the Greiner Group has been achieving high market share profits for years and has consequently become market leader in a number of regions already. The global markets for both business fields continually grow by approximately 8 to 10% per annum. During the fiscal year of 2007, Greiner Bio-One was able to increase its sales turnover by 10.6% and was consequently in a position to further expand its market shares.

The independent corporation Greiner Bio-One International AG sprang from the laboratory technology division of Greiner Holding AG in 2001. It is also owned by the Greiner family and specializes in the promising Preanalytics and Bioscience sectors. With a production and distribution network in more than 100 countries worldwide and approximately 1200 employees, the company has been extremely successful in both product divisions. Greiner Bio-One is a global leader in the HTS product sector for the pharmaceutical screening of active agents. In the area of specimen sampling devices, the Greiner Group has been achieving high market share profits for years and has consequently become market leader in a number of regions already. The global markets for both business fields continually grow by approximately 8 to 10% per annum. During the fiscal year of 2007, Greiner Bio-One was able to increase its sales turnover by 10.6% and was consequently in a position to further expand its market shares.

The independent corporation Greiner Bio-One International AG sprang from the laboratory technology division of Greiner Holding AG in 2001. It is also owned by the Greiner family and specializes in the promising Preanalytics and Bioscience sectors. With a production and distribution network in more than 100 countries worldwide and approximately 1200 employees, the company has been extremely successful in both product divisions. Greiner Bio-One is a global leader in the HTS product sector for the pharmaceutical screening of active agents. In the area of specimen sampling devices, the Greiner Group has been achieving high market share profits for years and has consequently become market leader in a number of regions already. The global markets for both business fields continually grow by approximately 8 to 10% per annum. During the fiscal year of 2007, Greiner Bio-One was able to increase its sales turnover by 10.6% and was consequently in a position to further expand its market shares.

The independent corporation Greiner Bio-One International AG sprang from the laboratory technology division of Greiner Holding AG in 2001. It is also owned by the Greiner family and specializes in the promising Preanalytics and Bioscience sectors. With a production and distribution network in more than 100 countries worldwide and approximately 1200 employees, the company has been extremely successful in both product divisions. Greiner Bio-One is a global leader in the HTS product sector for the pharmaceutical screening of active agents. In the area of specimen sampling devices, the Greiner Group has been achieving high market share profits for years and has consequently become market leader in a number of regions already. The global markets for both business fields continually grow by approximately 8 to 10% per annum. During the fiscal year of 2007, Greiner Bio-One was able to increase its sales turnover by 10.6% and was consequently in a position to further expand its market shares.